Maiken Keson-Brookes
Keine laufenden Positionen mehr
Vermögen: 224 974 $ am 31.03.2024
Aktive Positionen von Maiken Keson-Brookes
Unternehmen | Position | Beginn | Ende |
---|
Karriereverlauf von Maiken Keson-Brookes
Ehemalige bekannte Positionen von Maiken Keson-Brookes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RUBIUS THERAPEUTICS | General Counsel | 12.11.2019 | 15.11.2022 |
Corporate Secretary | 12.11.2019 | 15.11.2022 | |
UNIQURE N.V. | General Counsel | 01.12.2016 | 01.07.2017 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | General Counsel | 01.07.2010 | 01.06.2016 |
BIOGEN INC. | Corporate Officer/Principal | 01.01.2004 | 01.01.2009 |
SYNLOGIC, INC. | General Counsel | 01.12.2017 | 01.11.2019 |
Corporate Secretary | 01.11.2019 | - | |
Cxloyalty Inernational Ltd.
Cxloyalty Inernational Ltd. Miscellaneous Commercial ServicesCommercial Services Cxloyalty Inernational Ltd. provides marketing services to financial institutions and insurance companies. It offers sentinel card protection, a software protection, fraud insurance product for personal computer users, protection, insurance, travel, leisure products and services. The company was founded in 1971 and is headquartered in Slough, the United Kingdom. | General Counsel | - | - |
Corporate Secretary | - | - |
Ausbildung von Maiken Keson-Brookes
King's College London | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Vereinigtes Königreich | 3 |
Niederlande | 2 |
Operativ
General Counsel | 6 |
Corporate Secretary | 4 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BIOGEN INC. | Health Technology |
UNIQURE N.V. | Health Technology |
SYNLOGIC, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
Cxloyalty Inernational Ltd.
Cxloyalty Inernational Ltd. Miscellaneous Commercial ServicesCommercial Services Cxloyalty Inernational Ltd. provides marketing services to financial institutions and insurance companies. It offers sentinel card protection, a software protection, fraud insurance product for personal computer users, protection, insurance, travel, leisure products and services. The company was founded in 1971 and is headquartered in Slough, the United Kingdom. | Commercial Services |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Börse
- Insiders
- Maiken Keson-Brookes
- Erfahrung